Nail salons don’t usually make private equity pitch decks. Neither do salon suites or men’s barbershops. That’s changing fast. Townhouse, the UK-born nail salon brand backed by Cartesian Capital, the growth equity firm behind Burger King China, Tim Hortons, and Popeyes, grew revenue from £2.1 million ($2.86 million) to £19.4 million ($26.4 million) in three years, and now sits on a pipeline of more than 150 signed franchise locations across the UK and Europe, with several hundred more in advanced negotiation. It has reached a $130 million valuation on £48 million ($65.4 million) of total investment.
Townhouse isn’t alone. Boardroom Salon for Men, the Texas-based men’s grooming chain backed by LA private equity firm LightBay Capital, reported average franchisee revenue of $1.08 million in 2025, with its lowest-performing region still up 8% year to date in 2026 and its average region running more than double that. Image Studios, the salon-suite franchisor founded by former automotive-retail executive Jason Olsen, now operates 100-plus open locations against a pipeline of 190-200 more. These companies operate on three very different business models—a service brand, a membership brand, and a real estate landlord brand.
That convergence is the story. Beauty, long dismissed by institutional capital as too fragmented, too founder dependent, and too personal to systematize, is now being underwritten with the same playbook that built Massage Envy, European Wax Center, and the Quick-Service Restaurant (QSR) giants before them. “From day one, Townhouse has focused on a clear plan: Prove the concept and unit economics through our own salons and then achieve global scale through franchise partners,” Jonathan Millet, CEO of Townhouse, said to BeautyMatter.
Recurring revenue has become the underwriting standard. Investors are now buying visibility. Millet pointed to this directly, stating that Townhouse’s customer base created exceptional revenue visibility, with the vast majority of salon income coming from regular repeat visits booked in advance. Boardroom CEO Jeff Helfgott credited similar dynamics to the brand’s growth, attributing its growth numbers to higher ticket prices, more new-client traffic, and greater frequency.
Injectables have also shifted from indulgence to maintenance. The medical aesthetics market is projected to grow from roughly $24-$28 billion globally in 2026 to somewhere between $78 billion and $105 billion by the early 2030s, according to multiple industry forecasts, at a CAGR near 15%-16%. Neuromodulators alone account for nearly 10 million procedures annually in the US, and the average medspa patient’s age has dropped from 47 in 2018 to roughly 40 today, evidence that what was once an older, occasional-luxury category has become a routine, younger-skewing habit. That habitual, calendar-driven behavior is exactly the kind of demand pattern PE firms know how to scale.
Categories like gyms, dental, and veterinary care have already consolidated around scaled platforms over the past decades. According to Millet, beauty services are one of the last large, fragmented consumer categories without a dominant national or global brand, creating a huge opportunity. Helfgott sees the same setup industry-wide. “This is going to become a hotspot for investor activity. It’s a highly fragmented, growing industry with few scaled players. It’s recession-resistant and AI-proof…. There is plenty of capital looking for a safe haven,” he said.
Cartesian’s own logic, per Millet, illustrates how sponsors evaluate the category regardless of vertical. “A lot of the core franchising concepts map over from QSR. Success is built on delivering a high-quality product with strong consistency and working with sophisticated franchise partners who know their local markets. For QSR operators, beauty provides an opportunity to diversify.”
If beauty franchising has a frontier, it’s medical aesthetics—and it’s also where the model faces its hardest constraint: state medical boards. The US medspa market is estimated at $18.4-$26 billion in 2026, having grown roughly 64% in location count since 2018 to more than 9,500-12,000 facilities. But 2026 is, by far, the tightest enforcement year the sector has seen. New York’s 2026 statewide task force inspected 223 med pas and issued 87 citations, many tied to unlicensed staff performing procedures and “ghost” medical directors providing no real supervision.
California’s SB 351, effective January 2026, now bars management-services organizations from making billing, e-prescribing, or coding decisions that depend on clinical judgment. Ohio has closed more than 30 clinics over supervision and records failures. Georgia has moved to bar third parties from being paid to connect clinics with delegating physicians.
For franchisors, that means the medical director relationship can’t be treated as a checkbox. Medical director fees now run $1,500 to $8,000 a month depending on the depth of engagement required, and franchise agreements have to be rebuilt state by state. Jason Olsen, founder and CEO of Image Studios, noted to BeautyMatter that roughly half of his studio tenants already work in “medspa and injectables,” meaning the category is entering his ecosystem through independent operators renting suites rather than through Image’s own clinical licensing exposure— a structural hedge that pure-play medspa franchisors don't have.
Beauty has always sold relationships. Systemizing that relationship at scale is the central tension every franchisor is managing. Olsen framed Image Studio’s entire model around preserving relational value rather than replacing it. “Our franchise owners are essentially in the real estate and community business, not the service industry,” he said, precisely because the company’s structure lets the professional–client bond stay intact while the franchisee builds a separate, repeatable real estate business around it.
Helfgott sees consistency and intimacy as compatible only if growth is deliberately throttled. “I have seen more brands die of indigestion than starvation,” he said. “I’d rather have 3-5 new franchisees ramping well than sprinting to 100 units and spending the next decade fixing the system.” His view of the real threat to service quality isn’t operational systematization itself but rather labor.
Millet’s framing is that systematization enables quality, rather than eroding it, provided franchise partners are chosen carefully. “As we expand, the biggest challenge and area of focus for us is execution pace: onboarding the right franchise partners at the right pace while ensuring that quality does not dilute as the system scales.” Townhouse’s answer is to work exclusively with large, sophisticated multi-unit operators who so far are delivering quality metrics and customer outcomes, rather than opening the system to smaller, less-resourced franchisees.
Expect three things next. First, more QSR and fitness-sector operators are crossing into beauty, specifically because their playbook, including site underwriting, co-tenancy analysis, and SOP-driven consistency, transfers directly. Olsen’s own path from automotive retail is instructive here. “Real estate and location are a core competency of multi-unit retail and the site decision is half the business.” That operator profile, not a beauty background, is increasingly what sponsors are underwriting.
Second, expect continued consolidation pressure in categories that still lack a dominant national platform—such as nails, men’s grooming, and medical aesthetics—following the template gyms, dental, and veterinary care set over the past years.
And third, expect regulatory friction in medspas to become a genuine moat: The brands that build defensible, well-documented medical-director infrastructure now will be the ones capital backs when enforcement, not consumer demand, becomes the binding constraint on how fast the category can scale.